Home > Boards > US Listed > Biotechs >

Allogene Therapeutics (ALLO)

ALLO RSS Feed
Add ALLO Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 5/19/2022 1:36:05 PM - Followers: 2 - Board type: Free - Posts Today: 0

New message board for Allogene Therapeutics
ALLO
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ALLO News: Goldman Sachs Keeps a Hold Rating on Allogene Therapeutics (ALLO) 04:46 AM
ALLO News: Statement of Changes in Beneficial Ownership (4) 05/19/2022 01:41:22 PM
ALLO News: Allogene Therapeutics Announces Oral Presentation of Pre-Clinical Data Highlighting Improved Anti-Tumor Activity of Donor-Derived Allogeneic CAR T Cells at American Society of Gene and Cell Therapy (ASGCT) Annual Meeting 05/19/2022 04:30:00 AM
ALLO News: Allogene Therapeutics Named 2022 Bay Area “Best Place to Work” by San Francisco Business Times and Silicon Valley Business Journal 05/09/2022 04:30:00 AM
ALLO News: Allogene Therapeutics (ALLO) Received its Third Buy in a Row 05/05/2022 08:55:30 PM
News News Alert: Goldman Sachs Keeps a Hold Rating on Allogene Therapeutics (ALLO) 05/24/2022 04:46:41 AM
PostSubject
#17   ASGCT PR https://www.globenewswire.com/news-release/2022/05/19/2446950/0/en/Allo jondoeuk 05/19/22 01:36:05 PM
#16   New preclinical data https://aacrjournals.org/cancerrescommun/article/2/3/158/68 jondoeuk 03/23/22 11:08:02 PM
#15   Additional data https://allogene.com/resources/download/ALPHA-Study.pdf https:// jondoeuk 12/16/21 04:12:26 PM
#14   AS PR's https://www.globenewswire.com/news-release/2021/12/13/2350984/0/en/Allo jondoeuk 12/13/21 05:05:33 PM
#13   Abstracts ALPHA2 Study: ALLO-501A Allogeneic CAR T in LBCL, jondoeuk 11/04/21 02:19:52 PM
#12   ASH data https://www.globenewswire.com/news-release/2021/11/04/2327658/0/en/Allo jondoeuk 11/04/21 02:14:21 PM
#11   $ALLO: 2nd day of bouncing off bottom...... now $17.25 makinezmoney 10/14/21 09:37:26 AM
#10   New PR https://www.globenewswire.com/news-release/2021/06/04/2242102/0/en/Alloge jondoeuk 06/04/21 11:40:49 AM
#9   Allogene Therapeutics (NASDAQ:ALLO) was upgraded by analysts at conix 05/28/21 08:59:38 PM
#8   The PR https://www.globenewswire.com/news-release/2021/05/19/2232864/0/en/Alloge jondoeuk 05/19/21 09:58:06 PM
#7   The poster https://www.allogene.com/resources/download/AACR-2021-PD1-iTurboCAR.p jondoeuk 05/14/21 04:49:57 PM
#6   Link to the webcast https://allogene.zoom.us/webinar/register/WN_nyDYMLTnR9yi19r jondoeuk 05/14/21 04:48:56 PM
#5   Longer term data from the ALLO-501 PhI (ALPHA) jondoeuk 04/30/21 10:10:01 PM
#4   An internal program (to overcome rejection) will downregulating jondoeuk 04/03/21 08:59:36 PM
#3   From AACR: jondoeuk 03/10/21 07:02:29 PM
#2   From the recent call, ALLO have disclosed they jondoeuk 03/10/21 07:02:09 PM
#1   Preclinical data (ASH) https://ashpublications.org/blood/article/136/Supplement% jondoeuk 11/04/20 06:08:16 PM
PostSubject
Consent Preferences